Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient

An Yi Wang, Ang Yuan, Chien Hua Huang, Wei Tien Chang, Po Chin Liang, Tzu Hsin Lin, Shyr Chyr Chen

Research output: Contribution to journalArticle

Abstract

Peptic ulcer bleeding is thought to be a major cause of bleeding in patients with end-stage renal disease and is more complicated in uremic patients. We described a 41-year-old man with end-stage renal disease who underwent hemodialysis with refractory ulcer bleeding, failure to all traditional peptic ulcer treatments, and correction of uremic component, who has been successfully treated by using recombinant factor VIIa. There have been few case reports in dealing refractory upper gastrointestinal bleeding in uremic patients in the literature; and in this case report, we demonstrates that recombinant factor VIIa could be used as a rescue therapy in these highsurgical risk patients when medical therapy fails.

Original languageEnglish
Pages (from-to)1319.e1-1319.e4
JournalAmerican Journal of Emergency Medicine
Volume30
Issue number7
DOIs
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

Ulcer
Hemorrhage
Peptic Ulcer
Chronic Kidney Failure
Renal Dialysis
Therapeutics
recombinant FVIIa

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Wang, A. Y., Yuan, A., Huang, C. H., Chang, W. T., Liang, P. C., Lin, T. H., & Chen, S. C. (2012). Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient. American Journal of Emergency Medicine, 30(7), 1319.e1-1319.e4. https://doi.org/10.1016/j.ajem.2011.05.010

Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient. / Wang, An Yi; Yuan, Ang; Huang, Chien Hua; Chang, Wei Tien; Liang, Po Chin; Lin, Tzu Hsin; Chen, Shyr Chyr.

In: American Journal of Emergency Medicine, Vol. 30, No. 7, 01.01.2012, p. 1319.e1-1319.e4.

Research output: Contribution to journalArticle

Wang, AY, Yuan, A, Huang, CH, Chang, WT, Liang, PC, Lin, TH & Chen, SC 2012, 'Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient', American Journal of Emergency Medicine, vol. 30, no. 7, pp. 1319.e1-1319.e4. https://doi.org/10.1016/j.ajem.2011.05.010
Wang, An Yi ; Yuan, Ang ; Huang, Chien Hua ; Chang, Wei Tien ; Liang, Po Chin ; Lin, Tzu Hsin ; Chen, Shyr Chyr. / Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient. In: American Journal of Emergency Medicine. 2012 ; Vol. 30, No. 7. pp. 1319.e1-1319.e4.
@article{e0f92d73198745639af91c612574874a,
title = "Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient",
abstract = "Peptic ulcer bleeding is thought to be a major cause of bleeding in patients with end-stage renal disease and is more complicated in uremic patients. We described a 41-year-old man with end-stage renal disease who underwent hemodialysis with refractory ulcer bleeding, failure to all traditional peptic ulcer treatments, and correction of uremic component, who has been successfully treated by using recombinant factor VIIa. There have been few case reports in dealing refractory upper gastrointestinal bleeding in uremic patients in the literature; and in this case report, we demonstrates that recombinant factor VIIa could be used as a rescue therapy in these highsurgical risk patients when medical therapy fails.",
author = "Wang, {An Yi} and Ang Yuan and Huang, {Chien Hua} and Chang, {Wei Tien} and Liang, {Po Chin} and Lin, {Tzu Hsin} and Chen, {Shyr Chyr}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.ajem.2011.05.010",
language = "English",
volume = "30",
pages = "1319.e1--1319.e4",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders",
number = "7",

}

TY - JOUR

T1 - Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient

AU - Wang, An Yi

AU - Yuan, Ang

AU - Huang, Chien Hua

AU - Chang, Wei Tien

AU - Liang, Po Chin

AU - Lin, Tzu Hsin

AU - Chen, Shyr Chyr

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Peptic ulcer bleeding is thought to be a major cause of bleeding in patients with end-stage renal disease and is more complicated in uremic patients. We described a 41-year-old man with end-stage renal disease who underwent hemodialysis with refractory ulcer bleeding, failure to all traditional peptic ulcer treatments, and correction of uremic component, who has been successfully treated by using recombinant factor VIIa. There have been few case reports in dealing refractory upper gastrointestinal bleeding in uremic patients in the literature; and in this case report, we demonstrates that recombinant factor VIIa could be used as a rescue therapy in these highsurgical risk patients when medical therapy fails.

AB - Peptic ulcer bleeding is thought to be a major cause of bleeding in patients with end-stage renal disease and is more complicated in uremic patients. We described a 41-year-old man with end-stage renal disease who underwent hemodialysis with refractory ulcer bleeding, failure to all traditional peptic ulcer treatments, and correction of uremic component, who has been successfully treated by using recombinant factor VIIa. There have been few case reports in dealing refractory upper gastrointestinal bleeding in uremic patients in the literature; and in this case report, we demonstrates that recombinant factor VIIa could be used as a rescue therapy in these highsurgical risk patients when medical therapy fails.

UR - http://www.scopus.com/inward/record.url?scp=84865525829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865525829&partnerID=8YFLogxK

U2 - 10.1016/j.ajem.2011.05.010

DO - 10.1016/j.ajem.2011.05.010

M3 - Article

AN - SCOPUS:84865525829

VL - 30

SP - 1319.e1-1319.e4

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 7

ER -